Notice on the 2024 Annual General Meeting
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Notice on the 2024 Annual General Meeting
Filed with SSE ·
6ix hasn’t read this filing yet.
Zhuzhou Qianjin Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhuzhou Qianjin Pharmaceutical
- Announcement on Resignation of Director
- Announcement on Acceptance of Application for Purchasing Assets by Issuing Shares and Paying Cash and Related Transactions by Shanghai Stock Exchange
- Announcement on Changing Signatory Certified Public Accountant
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
- Announcement on Release of Pledge of Some Shares of Controlling Shareholders
Later from Zhuzhou Qianjin Pharmaceutical
- Announcement on Provision of Online Voting Reminder Service for General Meeting
- Announcement on Resolution of the 2024 Annual General Meeting
- Indicative Announcement on Reply to the Review Inquiry Letter of Application for Purchasing Assets by Issuing Shares and Paying Cash and Related Party Transactions
- Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
- Announcement on Outline of the 2024 Annual and Q1 2025 Performance Briefing
Follow Zhuzhou Qianjin Pharmaceutical into a list and get an email when it puts out news.
Follow Zhuzhou Qianjin Pharmaceutical